Paul Choi
Stock Analyst at Goldman Sachs
(4.29)
# 1,269
Out of 4,396 analysts
372
Total ratings
53.3%
Success rate
8.2%
Average return
Main Sectors:
Stocks Rated by Paul Choi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics | Maintained: Buy | $95 → $90 | $31.81 | +182.93% | 4 | Jun 5, 2026 | |
| URGN UroGen Pharma | Maintained: Hold | $16 → $18 | $28.18 | -36.12% | 23 | May 18, 2026 | |
| RGNX REGENXBIO | Maintained: Hold | $12 → $10 | $6.34 | +57.73% | 11 | May 14, 2026 | |
| CRVS Corvus Pharmaceuticals | Maintained: Buy | $40 | $11.17 | +258.10% | 3 | May 14, 2026 | |
| ARVN Arvinas | Maintained: Sell | $6 | $7.21 | -16.78% | 8 | May 12, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $112 → $116 | $67.68 | +71.39% | 35 | May 8, 2026 | |
| LNTH Lantheus Holdings | Maintained: Hold | $77 → $94 | $99.98 | -5.98% | 5 | May 7, 2026 | |
| EXEL Exelixis | Maintained: Buy | $50 | $52.99 | -5.64% | 8 | May 6, 2026 | |
| VIR Vir Biotechnology | Maintained: Buy | $21 | $8.51 | +146.77% | 25 | May 6, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $95 → $101 | $68.45 | +47.55% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.82 | - | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 | $213.23 | +19.59% | 25 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $52.87 | +41.86% | 12 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $3.14 | -4.46% | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $12 | $14.89 | -19.41% | 27 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 → $0.5 | $0.16 | +212.50% | 9 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $50 → $55 | $73.68 | -25.35% | 25 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $55 | $48.70 | +12.94% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 | $34.06 | -41.28% | 1 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.71 | n/a | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.69 | n/a | 25 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.05 | n/a | 5 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $10.63 | n/a | 19 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $57.91 | n/a | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $133.23 | $16.91 | n/a | 1 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $3.87 | n/a | 5 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $3.5 | $9.41 | n/a | 4 | Apr 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $7.06 | n/a | 8 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $9 | $10.94 | n/a | 5 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $17 | $84.57 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $7.41 | n/a | 1 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $150,000.00 | n/a | 2 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $135 | $165.24 | n/a | 4 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $18 → $20 | $56.23 | n/a | 5 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $165 | $103.23 | n/a | 2 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $1,144.68 | n/a | 1 | Apr 7, 2017 |
Vera Therapeutics
Jun 5, 2026
Maintained: Buy
Price Target: $95 → $90
Current: $31.81
Upside: +182.93%
UroGen Pharma
May 18, 2026
Maintained: Hold
Price Target: $16 → $18
Current: $28.18
Upside: -36.12%
REGENXBIO
May 14, 2026
Maintained: Hold
Price Target: $12 → $10
Current: $6.34
Upside: +57.73%
Corvus Pharmaceuticals
May 14, 2026
Maintained: Buy
Price Target: $40
Current: $11.17
Upside: +258.10%
Arvinas
May 12, 2026
Maintained: Sell
Price Target: $6
Current: $7.21
Upside: -16.78%
BridgeBio Pharma
May 8, 2026
Maintained: Buy
Price Target: $112 → $116
Current: $67.68
Upside: +71.39%
Lantheus Holdings
May 7, 2026
Maintained: Hold
Price Target: $77 → $94
Current: $99.98
Upside: -5.98%
Exelixis
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $52.99
Upside: -5.64%
Vir Biotechnology
May 6, 2026
Maintained: Buy
Price Target: $21
Current: $8.51
Upside: +146.77%
Cytokinetics
May 5, 2026
Reiterated: Buy
Price Target: $95 → $101
Current: $68.45
Upside: +47.55%
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $9.82
Upside: -
Apr 8, 2026
Maintained: Buy
Price Target: $255
Current: $213.23
Upside: +19.59%
Mar 10, 2026
Maintained: Buy
Price Target: $75
Current: $52.87
Upside: +41.86%
Mar 3, 2026
Maintained: Hold
Price Target: $3
Current: $3.14
Upside: -4.46%
Feb 25, 2026
Maintained: Sell
Price Target: $12
Current: $14.89
Upside: -19.41%
Feb 24, 2026
Downgraded: Hold
Price Target: $8 → $0.5
Current: $0.16
Upside: +212.50%
Dec 3, 2025
Maintained: Sell
Price Target: $50 → $55
Current: $73.68
Upside: -25.35%
Oct 29, 2025
Maintained: Buy
Price Target: $32 → $55
Current: $48.70
Upside: +12.94%
Sep 24, 2025
Rated: Hold
Price Target: $20
Current: $34.06
Upside: -41.28%
Feb 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.71
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $6.69
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Jul 31, 2024
Maintained: Hold
Price Target: $19
Current: $10.63
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: n/a
Current: $57.91
Upside: n/a
Nov 10, 2023
Maintained: Hold
Price Target: $133.23
Current: $16.91
Upside: n/a
Jun 28, 2023
Maintained: Buy
Price Target: $19
Current: $3.87
Upside: n/a
Apr 3, 2022
Downgraded: Hold
Price Target: $25 → $3.5
Current: $9.41
Upside: n/a
Nov 5, 2021
Maintained: Hold
Price Target: $8 → $7
Current: $7.06
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: $12 → $9
Current: $10.94
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: $15 → $17
Current: $84.57
Upside: n/a
Nov 9, 2020
Initiated Coverage: Buy
Price Target: $50
Current: $7.41
Upside: n/a
Aug 24, 2020
Maintained: Sell
Price Target: n/a
Current: $150,000.00
Upside: n/a
Jun 29, 2020
Downgraded: Hold
Price Target: $135
Current: $165.24
Upside: n/a
Mar 30, 2020
Upgraded: Hold
Price Target: $18 → $20
Current: $56.23
Upside: n/a
Nov 1, 2017
Maintained: Buy
Price Target: $135 → $165
Current: $103.23
Upside: n/a
Apr 7, 2017
Reiterated: Buy
Price Target: $90
Current: $1,144.68
Upside: n/a